AAAAAA
Results:
1-15
|
Results: 15
Authors:
KAKKAS I
KARMIRIS T
MALEKOU S
BALTATHAKIS I
GIGANTES S
GIANNAKAKIS A
PAGONIS M
KARAKASIS D
SKANDALIS A
HARHALAKIS N
NIKIFORAKIS E
Citation: I. Kakkas et al., AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR PATIENTS WITH ADVANCED HODGKINS-DISEASE (HD), Bone marrow transplantation, 21, 1998, pp. 571-571
Authors:
KARAKASSIS D
MALEKOU S
GIANNAKAKI A
SKANDALIS A
HARHALAKIS N
KAPSIMALIS V
KARATZA M
TZIOTZIOU I
PAGONIS M
KARMIRIS T
NIKIFORAKIS N
Citation: D. Karakassis et al., AUTOLOGOUS TRANSPLANTATION WITH ACTIVATED MARROW, Bone marrow transplantation, 21, 1998, pp. 572-572
Authors:
SKANDALIS A
ENCELL LP
LOEB LA
Citation: A. Skandalis et al., CREATING NOVEL ENZYMES BY APPLIED MOLECULAR EVOLUTION, Chemistry & biology, 4(12), 1997, pp. 889-898
Authors:
SKANDALIS A
DACRUZ AD
CURRY J
NOHTURFFT A
CURADO MP
GLICKMAN BW
Citation: A. Skandalis et al., MOLECULAR ANALYSIS OF T-LYMPHOCYTE HPRT(-) MUTATIONS IN INDIVIDUALS EXPOSED TO IONIZING-RADIATION IN GOIANIA, BRAZIL, Environmental and molecular mutagenesis, 29(2), 1997, pp. 107-116
Authors:
GIGANTES S
DELIMPASI S
MALEKOU S
PAGONI M
KARAKASIS D
KARMIRIS TH
BAKIRI M
MITSOULI C
SKANDALIS A
HARHALAKIS N
NIKIFORAKIS E
Citation: S. Gigantes et al., 4 CYCLES OF CHEMOTHERAPY FOR THE TREATMENT OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA AGED OVER 50 YEARS, Blood, 90(10), 1997, pp. 3824-3824
Authors:
SUZUKI M
CHRISTIANS FC
KIM B
SKANDALIS A
BLACK ME
LOEB LA
Citation: M. Suzuki et al., TOLERANCE OF DIFFERENT PROTEINS FOR AMINO-ACID DIVERSITY, Molecular diversity, 2(1-2), 1996, pp. 111-118
Authors:
BALTATHAKIS I
GOUGOPOULOU D
KOLOVOU A
KAKKAS I
AXARLIS S
KARMIRIS T
KARAKASIS D
SKANDALIS A
HARHALAKIS N
NIKOFORAKIS E
Citation: I. Baltathakis et al., SHORT-DURATION PREEMPTIVE THERAPY WITH GANCICLOVIR FOR THE MANAGEMENTOF CYTOMEGALOVIRUS-INFECTION AFTER ALLOGENEIC BONE-MARROW TRANSPLANT, Blood, 88(10), 1996, pp. 3770-3770
Authors:
BHATTACHARYYA NP
GANESH A
PHEAR G
RICHARDS B
SKANDALIS A
MEUTH M
Citation: Np. Bhattacharyya et al., MOLECULAR ANALYSIS OF MUTATIONS IN MUTATOR COLORECTAL-CARCINOMA CELL-LINES, Human molecular genetics, 4(11), 1995, pp. 2057-2064
Authors:
SKANDALIS A
CURRY J
ONEILL JP
NICKLAS JA
ALBERTINI RJ
GLICKMAN BW
Citation: A. Skandalis et al., ANALYSIS OF POINT MUTATIONS IN THE HPRT GENE OF CANCER-PATIENTS TREATED WITH RADIOIMMUNOGLOBULIN THERAPY, Environmental and molecular mutagenesis, 26(3), 1995, pp. 213-217
Authors:
SKANDALIS A
MALEKOU S
POULAKIDAS E
TSIONOS K
KAKKAS J
KATOPI D
KARMIRIS T
KARAKASIS D
HARHALAKIS N
NIKIFORAKIS E
Citation: A. Skandalis et al., BUSULFAN (BU), CYCLOPHOSPHAMIDE (CY) AND ETOPOSIDE (VP-16) AS A PREPARATIVE REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 86(10), 1995, pp. 3855-3855
Authors:
BHATTACHARYYA NP
SKANDALIS A
GANESH A
GRODEN J
MEUTH M
Citation: Np. Bhattacharyya et al., MUTATOR PHENOTYPES IN HUMAN COLORECTAL-CARCINOMA CELL-LINES, Proceedings of the National Academy of Sciences of the United Statesof America, 91(14), 1994, pp. 6319-6323
Authors:
SKANDALIS A
FORD BN
GLICKMAN BW
Citation: A. Skandalis et al., STRAND BIAS IN MUTATION INVOLVING 5-METHYLCYTOSINE DEAMINATION IN THEHUMAN HPRT GENE, MUTATION RESEARCH, 314(1), 1994, pp. 21-26
Authors:
APOSTOLIDIS J
HARHALAKIS N
SKANDALIS A
KATOPI D
SAKELLARIOU K
KARAKASIS D
KARMIRIS T
NIKIFORAKIS E
Citation: J. Apostolidis et al., TRANSPLANT-RELATED MORTALITY (TRM) - THE EXPERIENCE OF A NEW BONE-MARROW TRANSPLANT UNIT, Blood, 84(10), 1994, pp. 10000703-10000703
Authors:
GROSOVSKY AJ
SKANDALIS A
HASEGAWA L
WALTER BN
Citation: Aj. Grosovsky et al., INSERTIONAL INACTIVATION OF THE TK LOCUS IN A HUMAN B-LYMPHOBLASTOID CELL-LINE BY A RETROVIRAL SHUTTLE VECTOR, MUTATION RESEARCH, 289(2), 1993, pp. 297-308
Authors:
CURRY J
SKANDALIS A
HOLCROFT J
DEBOER J
GLICKMAN B
Citation: J. Curry et al., COAMPLIFICATION OF HPRT CDNA AND GAMMA T-CELL RECEPTOR SEQUENCES FROM6-THIOGUANINE RESISTANT HUMAN T-LYMPHOCYTES, MUTATION RESEARCH, 288(2), 1993, pp. 269-275
Risultati:
1-15
|